Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04400331 |
|---|---|
| Brief Title: | Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease |
| First Submitted : | May 19, 2020 |
| First Submitted that Met QC Criteria : | May 19, 2020 |
| First Posted : | May 22, 2020 |
| Last Update Submitted that Met QC Criteria : | October 31, 2023 |
| Last Update Posted : | November 2, 2023 |